Gengfu Xiao to Animals
This is a "connection" page, showing publications Gengfu Xiao has written about Animals.
Connection Strength
0.221
-
Immunoglobulin fragment F(ab')2 against RBD potently neutralizes SARS-CoV-2 in vitro. Antiviral Res. 2020 10; 182:104868.
Score: 0.026
-
Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020 03; 30(3):269-271.
Score: 0.025
-
A novel RSV F-Fc fusion protein vaccine reduces lung injury induced by respiratory syncytial virus infection. Antiviral Res. 2019 05; 165:11-22.
Score: 0.024
-
Novel neutralizing monoclonal antibodies against Junin virus. Antiviral Res. 2018 08; 156:21-28.
Score: 0.023
-
Fungal mannosylation enhances human papillomavirus 16 E7 therapeutic immunity against TC-1 tumors. Oncol Rep. 2018 Jan; 39(1):425-432.
Score: 0.022
-
Bovine PrPC directly interacts with alphaB-crystalline. FEBS Lett. 2005 Oct 10; 579(24):5419-24.
Score: 0.009
-
SARS-CoV-2 envelope protein causes acute respiratory distress syndrome (ARDS)-like pathological damages and constitutes an antiviral target. Cell Res. 2021 08; 31(8):847-860.
Score: 0.007
-
Structural basis for inhibition of the SARS-CoV-2 RNA polymerase by suramin. Nat Struct Mol Biol. 2021 03; 28(3):319-325.
Score: 0.007
-
Salvianolic acid C potently inhibits SARS-CoV-2 infection by blocking the formation of six-helix bundle core of spike protein. Signal Transduct Target Ther. 2020 10 06; 5(1):220.
Score: 0.007
-
Comparative Antiviral Efficacy of Viral Protease Inhibitors against the Novel SARS-CoV-2 In Vitro. Virol Sin. 2020 Dec; 35(6):776-784.
Score: 0.007
-
Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2. Protein Cell. 2020 10; 11(10):723-739.
Score: 0.007
-
Anti-SARS-CoV-2 activities in vitro of Shuanghuanglian preparations and bioactive ingredients. Acta Pharmacol Sin. 2020 Sep; 41(9):1167-1177.
Score: 0.007
-
Structural basis for the inhibition of SARS-CoV-2 main protease by antineoplastic drug carmofur. Nat Struct Mol Biol. 2020 06; 27(6):529-532.
Score: 0.006
-
Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease. Science. 2020 06 19; 368(6497):1331-1335.
Score: 0.006
-
A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020 03; 579(7798):270-273.
Score: 0.006
-
Calcium channel blockers reduce severe fever with thrombocytopenia syndrome virus (SFTSV) related fatality. Cell Res. 2019 Sep; 29(9):739-753.
Score: 0.006
-
Screening of FDA-Approved Drugs for Inhibitors of Japanese Encephalitis Virus Infection. J Virol. 2017 11 01; 91(21).
Score: 0.005
-
Quantitative Proteomic Analysis of Mosquito C6/36 Cells Reveals Host Proteins Involved in Zika Virus Infection. J Virol. 2017 06 15; 91(12).
Score: 0.005
-
Construction and Rescue of a Functional Synthetic Baculovirus. ACS Synth Biol. 2017 07 21; 6(7):1393-1402.
Score: 0.005
-
Antiviral activity of peptide inhibitors derived from the protein E stem against Japanese encephalitis and Zika viruses. Antiviral Res. 2017 05; 141:140-149.
Score: 0.005
-
An efficient RNA-cleaving DNA enzyme can specifically target the 5'-untranslated region of severe acute respiratory syndrome associated coronavirus (SARS-CoV). J Gene Med. 2007 Dec; 9(12):1080-6.
Score: 0.003
-
SARS coronavirus induces apoptosis in Vero E6 cells. J Med Virol. 2004 Jul; 73(3):323-31.
Score: 0.002